Sernas en es it fr

Sernas Brand names, Sernas Analogs

Sernas Brand Names Mixture

  • No information avaliable

Sernas Chemical_Formula


Sernas RX_link

Sernas fda sheet

Sernas FDA

Sernas msds (material safety sheet)

Sernas MSDS

Sernas Synthesis Reference

P. A. J. Janssen, Belg. pat. 577,977 (1959), C.A. 54, 4630c (1960); idem, Brit. pat. 895,309 corresp to U.S. pat. 3,438,991 (1962, 1969 to Janssen).

Sernas Molecular Weight

375.864 g/mol

Sernas Melting Point

151.5 oC

Sernas H2O Solubility

14 mg/L

Sernas State


Sernas LogP


Sernas Dosage Forms

Injection; Oral solution; Tablet

Sernas Indication

For the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy also used in Tourette's syndrome and Severe hyperactivity.

Sernas Pharmacology

Haloperidol is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Haloperidol has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Haloperidol has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Sernas Absorption


Sernas side effects and Toxicity

LD50=165 mg/kg (rats, oral)

Sernas Patient Information


Sernas Organisms Affected

Humans and other mammals